Devonian Health Group Inc.
GSD.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 447.88% | 580.44% | 654.31% | 416.78% | 127.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 447.88% | 580.44% | 654.31% | 416.78% | 127.64% |
| Cost of Revenue | 522.67% | 673.34% | 700.83% | 454.54% | 119.54% |
| Gross Profit | 335.67% | 447.43% | 578.53% | 351.89% | 140.94% |
| SG&A Expenses | 45.29% | 80.29% | 47.94% | 41.27% | 65.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.47% | 2.86% | 3.70% | 3.48% | 1.96% |
| Total Operating Expenses | 203.09% | 224.83% | 178.66% | 108.32% | 65.72% |
| Operating Income | 114.37% | 79.42% | 79.98% | 31.94% | -22.52% |
| Income Before Tax | 106.84% | 72.96% | 73.32% | 30.57% | -11.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 97.14% | 72.96% | 73.32% | 30.57% | -11.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.14% | 72.96% | 73.32% | 30.57% | -11.82% |
| EBIT | 114.37% | 79.42% | 79.98% | 31.94% | -22.52% |
| EBITDA | 132.30% | 94.75% | 93.95% | 35.18% | -33.61% |
| EPS Basic | 96.88% | 74.32% | 75.29% | 37.74% | -0.90% |
| Normalized Basic EPS | 105.71% | 74.10% | 74.84% | 37.89% | -0.72% |
| EPS Diluted | 97.06% | 70.59% | 71.48% | 40.82% | 8.11% |
| Normalized Diluted EPS | 105.71% | 74.10% | 74.84% | 37.89% | -0.72% |
| Average Basic Shares Outstanding | 3.52% | 5.79% | 8.25% | 11.41% | 12.09% |
| Average Diluted Shares Outstanding | 3.52% | 5.79% | 8.25% | 11.41% | 12.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |